Previous Page  14 / 15 Next Page
Information
Show Menu
Previous Page 14 / 15 Next Page
Page Background

Page 35

J u l y 2 3 - 2 4 , 2 0 1 8 | R o m e , I t a l y

allied

academies

Joint Event on

Cardiology Congress 2018 & Microbe Infection 2018

Biomedical Research

|

ISSN: 0976-1683

|

Volume 29

2

nd

World Congress on

CARDIOLOGY

MICROBIOLOGY AND MICROBIAL INFECTION

&

39

th

Annual Congress on

Reza Nassiri, Biomed Res 2018, Volume 29 | DOI: 10.4066/biomedicalresearch-C1-002

THREATS OF ANTIBIOTIC RESISTANCE

Reza Nassiri

Michigan State University, USA

G

lobal consumption of antibiotics has increased nearly 40% in the last

decade. The incredible rapid resistance of antibiotic resistance which is

taking place worldwide is not only a serious threat to the practice of modern

medicine, but equally important, a threat to global public health. This urgent

issue is so alarming that it caught the attention of G-20 Summit in both China

(2016) and Germany (2017), let alone the U.N. Assembly in 2016 had called

for a special meeting of “superbugs” which focused on the escalating drug

resistance with respect to the sexually transmitted disease gonorrhea and

carbapenem resistant

Enterobacteriaceae

. While the causes of antibiotic

resistance are complex, certainly human behavior play a significant role in

the spread of antibiotic resistant genes. In addition to the human behavior,

the drivers of resistance include agriculture sector, animal husbandry,

household and industry – these factors contribute significantly to the spread

of the resistant genes within the ecosystem. Such resistant mechanisms are

continuously emerging globally, which threatens our ability to treat common

infections, resulting in increased death, disability and costs. Since the

development and clinical use of penicillins, nearly 1000 resistant-related beta-

lactamases that inactivate various types of antibiotics have been identified.

The emergence of resistance to last-resort treatments known as extended-

spectrum cephalosporins (ESCs) is now eminent. The five riskiest superbugs

are recognized as (1) the original one:

Staphylococcus Aureus

(MRSA), (2) the

hospital lurkers: Clostridium Difficile and Acinetobacter, (3) the food borne

pathogens:

Escherichia Coli

and

Salmonella

, (4) The sexually-transmitted

infections: Gonorrhea and Chlamydia, and (5) TB. India is a typical example

of encountering the deadly bacterial resistance. The high prevalence of the

mrc-1

gene in

E. Coli

samples both in animals and raw meat, with the number

of positive-testing samples are increasing each year in China. On average,

more than 20 percent of bacteria in the animal samples and 15 percent of the

raw meat samples carried the

mrc-1

gene. Numerous European countries

have reported the existence of

mrc-1

gene in the isolates from human,

isolates from animals used for food, isolates from food, and isolated from the

environment. In conclusion, pathogens rapidly develop mutations that render

current treatments ineffective – resistance to carbapenems, one of the ‘last

lines’ of antibiotics, is widespread and has been observed in numerous

countries. Therefore, there is an urgent need between research universities

and industry aimed at developing novel antimicrobial agents to save the

practice of modern medicine.

Reza Nassiri is a former Associate Dean of Global

Health at the Michigan State University (MSU). He

also served as MSU director of Institute of Internation-

al Health. He is currently Professor of Pharmacology

and Toxicology, Professor of Family and Community

Medicine, and, lecturer in Global Health, Infectious

Diseases and Tropical Medicine. He currently works

on international public health issues relating to infec-

tious diseases and has expertise in global health. He

has made contributions in various fields of medical

sciences including clinical investigation and health

education. On the basis of his extensive experience

and expertise in chronic infectious diseases including

HIV/AIDS, TB, antimicrobial resistance and human gut

microbiome, he has developed clinical research pro-

grams in Brazil, Haiti, Dominican Republic and Mexico.

He had served as editorial board member for the jour-

nal of HIV and AIDS Review.

Reza.Nassiri@hc.msu.edu

BIOGRAPHY